• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 4 months ago by International Alliance.
      • This topic was modified 6 years, 4 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Elisabeth Zahnd, Switzerland

      Elisabeth Zahnd, Switzerland

    • Ali Var, Turkey

      Ali Var, Turkey

    • Carlos Alberto Arango, Colombia

      Carlos Alberto Arango, Colombia

    • Jose Rivero Muñoz, Mexico

      Jose Rivero Muñoz, Mexico

    • Angelique van der Lit-van Veldhuizen, Netherlands

      Angelique van der Lit-van Veldhuizen, Netherlands

    • Liam Dwyer, England

      Liam Dwyer, England

    • Malu Araujo Ribeiro, Brazil

      Malu Araujo Ribeiro, Brazil

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • David Watson, Scotland

      David Watson, Scotland

    • Osiel Mendoza, USA

      Osiel Mendoza, USA

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Wilfried Leusing, Germany

      Wilfried Leusing, Germany

    • Jean

      Jean
      jean

    • Andrea Zicchieri, Italy

      Andrea Zicchieri, Italy
      AndreaZicchieri_conSLAncioItaly

    • Shay Rishoni, Israel

      Shay Rishoni, Israel

    • Diana Fernandez, Argentina

      Diana Fernandez, Argentina

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Barry de Reuver, Netherlands

      Barry de Reuver, Netherlands

    • Jason Goodman, USA

      Jason Goodman, USA

    • Francisco Perez Palop, Spain

      Francisco Perez Palop, Spain

    • Angie Bordaen, Belgium

      Angie Bordaen, Belgium

    • Lee Millard, England

      Lee Millard, England

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Michael Lee, Australia

      Michael Lee, Australia

    • Mark Miller, UK

      Mark Miller, UK

    • Chen Chun-Chin, Malaysia

      Chen Chun-Chin, Malaysia

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Timmy, Belgium

      Timmy, Belgium

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • Steve Lufkin, USA

      Steve Lufkin, USA
      IMG_3993

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Nicholas (Nic) Bowman, South Africa

      Nicholas (Nic) Bowman, South Africa

    • Dick Dayton, USA

      Dick Dayton, USA

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Andres Estevez Guersznik, Ireland

      Andres Estevez Guersznik, Ireland

    • Frank Taylor, USA

      Frank Taylor, USA

    • Rob Tison, USA

      Rob Tison, USA

    • Maurice Leclerc, Canada

      Maurice Leclerc, Canada

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Fernando Ocampo Cardona, Colombia

      Fernando Ocampo Cardona, Colombia

    • Zabun Nassar, England

      Zabun Nassar, England

    • Lineke Veenstra, Netherlands

      Lineke Veenstra, Netherlands

    • Paul Launer, USA

      Paul Launer, USA

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login